Veeva Systems Inc. (VEEV) Analyst Ratings & Price Targets

Veeva Systems Inc.

VEEV · NYSE

Analyst Consensus

Buy

24 analysts

$264

Current

—

Low

$300

Average

—

High

Average target implies +13.63% versus the current price.

Analyst Ratings Synthesis

The supplied consensus is Buy across 24 analysts, with a mean price target of $235 versus the latest $211.86 close. No low or high consensus targets are provided, so the formal spread and target clustering cannot be measured. Individual published figures range from Simply Wall St’s reported $165.00 updated target to MarketBeat’s $247.74 target and TipRanks’ $263.52 average, underscoring substantive disagreement over valuation and outlook. Revisions during or around the week were directionally cautious: Citigroup moved to Neutral, Wall Street Zen downgraded Buy to Hold, and Simply Wall St cited a reduction from about $232.80 to $165.00. The evidence does not identify the most or least bullish named analyst.

Rating Actions

1 firm captured

Firm	Analyst	Rating	Price Target	Upside	Date	Source
Wall Street Zen	—	Hold Downgrade	—	—	Aug 3, 2026	Open the report this row came from

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

CANACCORD GENUI

CITIGROUP

GOLDMAN SACHS

GUGGENHEIM SEC.

JEFFERIES & CO.

JP MORGAN SECUR

KEYBANC CAP MKT

MORGAN STANLEY

NEEDHAM & CO.

OPPENHEIMER HLD

PIPER SANDLER

RAYMOND JAMES

RBC CAPITAL

STIFEL NICOLAUS

TD COWEN

TELSEY ADVISORY

TRUIST SECURITI

UBS

WELLS FARGO SEC

WILLIAM BLAIR

ZACKS RESEARCH

Symbol: VEEV
Type: Stock
Sector: Technology
Industry: Services-Prepackaged Software
Exchange: NYSE

Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

Key Issues

Bullish view

FY2026 revenue increased to $3.2 billion from $2.7 billion, while net income rose to $0.9 billion from $0.7 billion. Supporters view simultaneous top-line and earnings growth as evidence that Veeva’s software model is scaling.

Bearish view

The supplied figures are annual comparisons only and provide no bookings, retention, margin, or forward-growth detail. Without those indicators, the durability of the latest growth and profitability cannot be established.

Analyst Consensus

See all

Buy

24 analysts

$264

Current

—

Low

$300

Average

—

High

Average target implies +13.63% versus the current price.

Earnings History

BeatMissNo estimate

Veeva Systems Inc.

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers